Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
SVRA similar filings
- 11 Apr 06 Adventrx Signs Definitive Merger Agreement with SD Pharmaceuticals
- 6 Apr 06 Adventrx Presents Positive Thiovir Preclinical Results
- 27 Mar 06 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
- 20 Mar 06 Adventrx to File Amended 2005 Third Quarter to Reflect Accounting for July 2005 Financing Under Eitf 00-19
- 1 Mar 06 Unregistered Sales of Equity Securities
- 15 Feb 06 CoFactor Clinical Update Announced at BIO CEO
- 6 Feb 06 Entry into a Material Definitive Agreement
Filing view
External links
Exhibit 7.2
March 20, 2006
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Gentlemen:
We have read Item 4.02 included in the Form 8-K dated March 20, 2006 of ADVENTRX Pharmaceuticals, Inc. (Commission file No. 001-32157) filed with the Securities and Exchange Commission and are in agreement with the statements contained therein as they relate to our firm.
/s/ J.H. Cohn LLP
J.H. Cohn LLP